The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Patients (p) with advanced melanoma receiving rescue surgery (RS), BRAF inhibitors (BRAFi), immunotherapy (IT) or chemotherapy (CT) in an off-protocol, routine clinical setting.
Jose Luis Cuadra-Urteaga
No relevant relationships to disclose
Jose Luis Manzano
No relevant relationships to disclose
Laura Layos
No relevant relationships to disclose
Cristina Buges
No relevant relationships to disclose
Maria Teresa Fernandez-Figueras
No relevant relationships to disclose
Anna Martinez-Cardus
No relevant relationships to disclose
Alberto Indacochea
No relevant relationships to disclose
Sara Ahlal
No relevant relationships to disclose
Laia Vila
No relevant relationships to disclose
Maria de los Llanos Gil
No relevant relationships to disclose
Aram Boada
No relevant relationships to disclose
Carolina Sanz
No relevant relationships to disclose
Ana Munoz
No relevant relationships to disclose
Vicente Ruiz Porras
No relevant relationships to disclose
Sara Bystrup
No relevant relationships to disclose
Eva Martinez-Balibrea
No relevant relationships to disclose